Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 19, 2015 - Issue 12
Submit an article Journal homepage
327
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes

Elisabetta MandosiSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Elisa GiannettaSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Tiziana FilardiSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Manuela LococoSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Camilla BertoliniSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Mara FallarinoSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Daniele GianfrilliSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Mary Anna VenneriSapienza University, Departement of Histology and Embryology, Rome, Italy
,
Luisa LentiSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
,
Andrea LenziSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
&
Susanna MoranoSapienza University of Rome, Policlinico Umberto I, Department of Experimental Medicine, Viale del Policlinico 155, 00161, Rome, Italy+390 649 978 381; +390 649 978 381; [email protected]
 show all
Pages 1617-1622 | Published online: 15 Jul 2015

Bibliography

  • Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005;6:21-9
  • Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74
  • Phé V, Rouprêt M. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies. Diabetes Metab 2012;38(1):1-13
  • Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev 2007(1):CD002187
  • Kanwar M, Agarwal R, Barnes M, et al. Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts. Curr Heart Fail Rep 2013;10(1):26-35
  • Giannetta E, Isidori AM, Galea N, et al. Chronic Inhibition of cGMP phosphodiesterase 5A improves diabetic cardiomyopathy: a randomized, controlled clinical trial using magnetic resonance imaging with myocardial tagging. Circulation 2012;125(19):2323-33
  • Giannetta E, Feola T, Gianfrilli D, et al. Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials. BMC Med 2014;12(1):185
  • Santi D, Giannetta E, Isidori AM, et al. Therapy of endocrine disease: effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: a meta-analysis. Eur J Endocrinol 2014
  • Morano S, Mandosi E, Fallarino M, et al. Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study. Eur Urol 2007;52(6):1768-74
  • Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26
  • De Meyer GRY, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis 1997;39:325-42
  • Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC. Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis 2011;10:211
  • Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. Endothelial dysfunction as a target for prevention of cardiovascular disease. J Am Coll Cardiol 1995;26:1235-41
  • Versari D1, Daghini E, Virdis A, et al. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009;32(Suppl 2):S314-21
  • Iribarren C. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001;103:2668-73
  • Burnett LA. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in Type 2 diabetic men with erectile dysfunction. J Urol 2009;181(1):245-51
  • Vestweber D, Blanks JE. Mechanism that regulate the function of selectins and their ligands. Physiol Rev 1999;79(1):181-213
  • Ayala JE, Bracy DP, Julien BM, et al. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 2007;56(4):1025-33
  • Tooke JE, Goh KL. Endotheliopathy precedes type 2 diabetes. Diabetes Care 1998;21:2047-9
  • Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997;46(Suppl 2):S9-S13
  • Sabatini S, Sgrò P, Duranti G, et al. Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. Acta Biochim Pol 2011;58(2):237-41
  • Phillips BG, Kato M, Pesek CA, et al. Sympathetic activation by sildenafil. Circulation 2000;102:3068-73

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.